Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression

Author： Fang Song  

Publisher： Springer Publishing Company

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.13, Iss.2, 2013-05, pp. : 127-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2311-2317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 10, 2015-10 ,pp. : 2311-2317

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1945-1956

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepcidin and DNA promoter methylation in hepatocellular carcinoma

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Clinical Significance of PCDH10 Promoter Methylation in Patients with Bladder Transitional Cell Carcinoma

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-11 ,pp. : 219-224

Karger

Access to resources Recommend Favorite